Rottapharm Biotech Srl

Italian research company at Monza in Lombardy, kept by the founding Rovati family when the Rottapharm Madaus pharmaceutical business was sold to Meda in 2014, and carrying on the group's research work of more than fifty years. Discovers and develops medicines for osteoarthritis, pain, inflammation and immunology, takes compounds through preclinical work and early clinical trials, and licenses them to pharmaceutical partners for later development and sale.